CARE Ratings Revises Mukka Proteins' Outlook to Stable; Reaffirms Ratings
Mukka Proteins Ltd · Others (Uncategorized) · 07 Oct 2026, 10:15 pm
CARE Ratings Revises Mukka Proteins' Outlook to Stable; Reaffirms Ratings CARE Ratings reaffirmed Mukka Proteins Limited’s bank facilities at CARE BBB-/CARE A3, revising the outlook to Stable from Negative on 7th Oct'26. The revision reflects strong Q1FY27 performance, where consolidated revenue jumped ~187% YoY to ₹490 crore, driven by a ~93% increase in realisations and ~49% volume growth with PBILDT margins above 9%. Liquidity is supported by ₹47 crore raised via equity warrants and an unexecuted order book of ₹500–550 crore, offset by high working capital intensity and raw material price volatility.
Original exchange filing (PDF)
More announcements from Mukka Proteins Ltd
- Intimation of Investor Presentation - Q2 & FY-27. · 10 Nov 2026
- Intimation of Press Release. · 08 Nov 2026
- Intimation of revision of terms of investment in Swachha Eco Solutions Private Limited. · 07 Nov 2026
- Financial Results for the quarter and half year ended 30th September 2026. · 07 Nov 2026
- Mukka Proteins Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 07 Nov 2026
- Intimation of Statement of Deviation and Variation for the quarter ended 30th September 2026. · 07 Nov 2026
- Intimation of Outcome of Board Meeting · 07 Nov 2026
- MUKKA PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 07 Nov 2026
